Inventor · disambiguated record
Sungyoo Cho
Also filed as: CHO SUNGYOO
4 granted patents·9 pending applications·5 citations·filing 2019–2024
66Inventor score
Top patents by PatentIndex Score
13 records- 0192US11970547B2Anti-HER2 antibody or antigen-binding fragment thereof, and chimeric antigen receptor comprising sameGC CELL CORP·Filed 2023·Granted Apr 30, 2024·2 cites·21 claims
- 0292US11649294B2Anti-HER2 antibody or antigen-binding fragment thereof, and chimeric antigen receptor comprising sameGC CELL CORP·Filed 2020·Granted May 16, 2023·3 cites·24 claims
- 0385US12410261B2Anti-HER2 antibody or antigen-binding fragment thereof, and chimeric antigen receptor comprising sameGC CELL CORP·Filed 2024·Granted Sep 9, 2025·0 cites·20 claims
- 0458US2025282845A1Fusion proteins comprising chimeric antigen receptors and il-15GC CELL CORP·Filed 2022·Application pending·0 cites
- 0553US2023242894A1Novel transplantation cells having reduced immunogenicityGC CELL CORP·Filed 2021·Application pending·0 cites
- 0653US2025073264A1Chimeric antigen receptor comprising an anti-her2 antibody or antigen-binding fragment thereof and natural killer cells comprising the sameARTIVA BIOTHERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0752US2024180962A1Treatment of cancer with nk cells and a cd20 targeted antibodyARTIVA BIOTHERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0850US2024366663A1Chimeric antigen receptor comprising an anti-cd19 antibody or antigen-binding fragment thereof and natural killer cells comprising the sameARTIVA BIOTHERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0948US2024366664A1Treatment of cancer with nk cells and an egfr targeted antibodyARTIVA BIOTHERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1048US2024197778A1Treatment of cancer with nk cells and a her2 targeted antibodyARTIVA BIOTHERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1147US2024115704A1Treatment of cancer with nk cells and a cd38-targeted antibodyARTIVA BIOTHERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1247US2024060046A1Expanded and stimulated natural killer cellsARTIVA BIOTHERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1343US12398372B2Method for culturing cord blood-derived natural killer cells using transformed T-cellsGREEN CROSS LAB CELL CORP·Filed 2019·Granted Aug 26, 2025·0 cites·11 claims
Join the waitlist — get patent alerts
Get an alert when Sungyoo Cho files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →